AmgenvsInnoviva

AMGN and INVA stock compared: price, dividend, valuation and results, from SEC filings.

AMGN

Amgen Inc.

$446.46

Value $241B

-2.50%
AMGN's page

Amgen (AMGN) has a market value of $241B and Innoviva (INVA) $1.4B. Over the last year, with dividends, AMGN moved +34.3% and INVA -16.3%. The P/E is 25.6 for AMGN and 7.0 for INVA. Dividend yield: AMGN 2.23%, INVA none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    AMGN$241B

    INVA$1.4B

    AMGN is 177 times INVA

  • Revenue, 12 months

    AMGN$38.9B

    INVA$438M

    AMGN is 89 times INVA

  • Net income, 12 months

    AMGN$9.4B

    INVA$193M

    AMGN is 49 times INVA

  • Operating margin

    AMGN32.4%

    INVA38.8%

    6.4 points apart

  • ROIC

    AMGN16.2%

    INVA9.5%

    6.7 points apart

  • P/E

    AMGN25.6

    INVA7.0

    AMGN is 3.6 times INVA

  • Dividend yield

    AMGN2.2%

    INVA0.0%

    2.2 points apart

  • 5-year return

    AMGN+151.3%

    INVA+6.6%

    144.7 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

AMGN+151.3%

INVA+6.6%

10020020222023202420252026
Returns by period
PeriodAMGNWith dividendsINVAWith dividends
1 year since November 17, 2025+34.3%Price +30.7%-16.3%Price -16.3%
3 years since November 17, 2023+82.6%+22.2% a yearPrice +68.2%+34.0%+10.3% a yearPrice +34.0%
5 years since November 17, 2021+151.3%+20.2% a yearPrice +116.9%+6.6%+1.3% a yearPrice +6.6%
10 years since November 18, 2016+311.2%+15.2% a yearPrice +207.4%+68.6%+5.4% a yearPrice +68.6%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

AMGNAmgenINVAInnoviva

Valuation

AMGNINVA
Valuation
Price$446.46$18.39
Market value$241B$1.4B
Enterprise value (EV)$281B$1.0B
P/E25.67.0
P/E, 5-year median23.06.1
P/B16.81.2
EV/EBIT22.36.1
Free cash flow yield4.0%13.4%

Results and growth

AMGNINVA
Results and growth
Revenue, 12 months$38.9B$438M
Net income, 12 months$9.4B$193M
Free cash flow, 12 months$9.6B$183M
Earnings per share, 12 months$17.25$2.61
Revenue growth, year on year10.0%14.7%
Revenue growth a year, past+7.6%over 5 years+4.1%over 5 years
EPS growth a year, past+2.9%over 5 years+10.3%over 5 years

Margins and returns on capital

AMGNINVA
Margins and returns on capital
Gross margin70.9%74.5%
Operating margin32.4%38.8%
Net margin24.1%44.1%
ROIC16.2%9.5%
ROE87.8%16.4%

Balance sheet

AMGNINVA
Balance sheet
Cash$13.2B$581M
Total debt$54.0B$270M
Net debt / EBITDA2.3–
Interest cover4.8×8.6×

Dividends and buybacks

AMGNINVA
Dividends and buybacks
Dividend yield2.2%–
Dividend per share, 12 months$9.94–
Dividend growth a year, past+8.1%over 5 years–
Buyback yield–0.3%
Shareholder yield2.2%0.3%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: AMGN or INVA

Didn't find what you were looking for?

Ask us
Which is bigger, Amgen or Innoviva?

By market value, Amgen ($241B) is about 176.7 times Innoviva ($1.4B), at today's prices.

How did AMGN and INVA stock do over the last 10 years?

Since November 18, 2016, AMGN's price moved +207.4% and INVA's +68.6%. With dividends: AMGN +311.2% (+15.2% a year), INVA +68.6% (+5.4% a year). Past returns do not predict future ones.

Which pays the higher dividend, AMGN or INVA?

The dividend yield at today's price is 2.23% for Amgen and none for Innoviva. Over the last twelve months they paid $9.94 and – per share.

What is the P/E of AMGN and INVA?

At today's price, the P/E is 25.6 for AMGN and 7.0 for INVA. The median of the last five years was 23.0 and 6.1, which shows where each stands against its own past.

Which has the higher profit margins, Amgen or Innoviva?

Over the last twelve months, the net margin was 24.1% for Amgen and 44.1% for Innoviva, and the operating margin 32.4% and 38.8%. Revenue was $38.9B and $438M.

Which is the better investment, Amgen or Innoviva?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.